Homotaurine Treatment Enhances CD4⁺ and CD8⁺ Regulatory T Cell Responses and Synergizes with Low-Dose Anti-CD3 to Enhance Diabetes Remission in Type 1 Diabetic Mice.

Combined treatment with homotaurine and proinsulin/alum treatments increased the mean time of disease remission from 14 wk (for the best dose of homotaurine monotherapy) to 24 wk, although this did not reach statistical significance.

also in 111,027 other papers